Munafa Stock Market Course + Intraday & FNO calls 
LLY announcements Eli Lilly And Company announcements and dividends declared NYSE
Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY
Eli Lilly And Company LLY listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Eli Lilly And Company LLY
: Eli Lilly gets FDA complete response letter for skin treatment after inspection of third-party facility
APEli Lilly & Co. said Monday the U.S. Food and Drug Administration has issued a complete response letter for its lebrikizumab, a treatment for moderate-to-severe atopic dermatitis, after an inspection at a third-party manufacturer. The letter, which means
Announcement as on 02 October 2023
: Eli Lilly set to dominate obesity drug market into the next decade, analysts say
Eli Lilly & Co. LLY is best positioned to dominate the fast-growing U.S. market for obesity drugs into the 2030s, BMO Capital Markets analysts said in a report late Thursday. Although Novo Nordisk NVO, maker of Ozempic and Wegovy, is likely to maintain sig
Announcement as on 22 September 2023
Are Wall Street Analysts Wrong About Eli Lilly Stock?
Eli Lilly (NYSE: LLY) has been a scorching hot buy in 2023 -- its shares are up more than 55% so far this year. But with the stock trading now at a multiple of 80 times earnings, it certainly isn't cheap. And if you go by Wall Street's price targets, you m
Announcement as on 22 September 2023
: Eli Lilly, Boehringer Ingelheim’s Jardiance gets FDA approval for chronic kidney disease
Eli Lilly & Co. LLY and Boehringer Ingelheim said Friday that the U.S. Food and Drug Administration has approved their blockbuster drug Jardiance, already used for heart failure and diabetes, as a treatment for adults with chronic kidney disease. The agenc
Announcement as on 22 September 2023
: Eli Lilly reports positive results from study of thyroid cancer treatment
Eli Lilly & Co. LLY on Tuesday reported positive results from a study evaluating its targeted therapy Retevmo versus the current standard initial treatments for patients with advanced or metastatic rearranged during transfection (RET)-mutant medullary thyr
Announcement as on 22 August 2023
Announcements by Eli Lilly And Company first page | Next page | Prev page |
LLY Eli Lilly And Company current price & indicator signals
Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 22 Fri May 2026 | 1065.24 | 1044.00 to 1070.34 | 2.26% | 0.75 times |
| 21 Thu May 2026 | 1041.65 | 1022.00 to 1047.30 | 2.28% | 1 times |
| 20 Wed May 2026 | 1018.46 | 1003.69 to 1037.88 | -0.29% | 0.48 times |
| 19 Tue May 2026 | 1021.41 | 984.60 to 1021.80 | 3.36% | 1.41 times |
| 18 Mon May 2026 | 988.19 | 978.87 to 1003.00 | -1.66% | 0.38 times |
| 15 Fri May 2026 | 1004.92 | 997.41 to 1014.38 | -0.18% | 1.04 times |
| 14 Thu May 2026 | 1006.70 | 996.01 to 1018.17 | -0.89% | 0.65 times |
| 13 Wed May 2026 | 1015.75 | 992.00 to 1022.82 | 2.61% | 1.29 times |
| 12 Tue May 2026 | 989.87 | 971.17 to 997.52 | 2.37% | 1.12 times |
| 11 Mon May 2026 | 966.99 | 943.26 to 995.00 | 1.95% | 1.3 times |
| 08 Fri May 2026 | 948.45 | 947.51 to 980.00 | -2.72% | 1.32 times |
| 07 Thu May 2026 | 974.96 | 967.10 to 989.00 | -1.22% | 1.29 times |
Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared NYSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
